Regulatory and Health-Claim Approval Risks Affecting Probiotic Promotion Activities in Europe
First written in FY2018-Q1. 19 of 20 entries say "Restated". Latest entry: FY2023-Q3.
The whole theme swung hardest in 2021: 2 of 11 companies on the "Worse" side.
15 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「In the region, amid strict regulations on activities to promote probiotics, the Company pursued various initiatives to obtain approval for health claims and sought sustainable growth by developing sales activities tailored to the characteristics of each country's market, taking advantage of growing health awareness.」
Given Europe's strict regulations and the challenge of obtaining approval for health claims, the Company continues efforts to obtain approval and sales activities tailored to market characteristics. - FY2022-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims. - FY2022-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims. - FY2022-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims. - FY2021RestatedAnnual report
「For example, health claims relating to probiotics are not permitted in Europe, restricting how the Group can promote its products. However, there is no guarantee that such regulations will not be introduced in other countries.」
Continues to describe European health claim regulations as a risk restricting how the products can be promoted. - FY2021-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims and sales activities tailored to the characteristics of each market. - FY2021-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims. - FY2021-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Amid continuing strict regulations on probiotic promotion activities in Europe, the Company continues efforts to obtain approval for health claims. - FY2020RestatedAnnual report
「Health claims relating to probiotics are not permitted in Europe, restricting how the Group can promote its products. However, there is no guarantee that such regulations will not be introduced in other countries.」
Continues to describe European health claim regulations as a risk restricting how the products can be promoted. - FY2020-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2020-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2020-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2019RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2019-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2019-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2019-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Strict regulations apply to probiotic promotion activities in Europe, and the Company continues efforts to obtain approval for health claims. - FY2018RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we worked to increase sales while pursuing various initiatives toward approval of health claims.」
The Company regards European health claim regulations as a challenge and continues efforts to obtain approval. - FY2018-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Continues to describe the situation in which strict regulations apply to probiotic promotion activities in Europe and efforts to obtain approval for health claims remain a challenge. - FY2018-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Continues to describe the situation in which strict regulations apply to probiotic promotion activities in Europe and efforts to obtain approval for health claims remain a challenge. - FY2018-Q1First statedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, the Company is pursuing various initiatives to obtain approval for health claims.」
Describes the situation in which strict regulations apply to probiotic promotion activities in Europe and approval of health claims remains a challenge.